Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155008 · ClinicalTrials.gov registry record · Phase 4
Nutrition and Pharmacological Algorithm for Oncology Patients Study
A Phase 4 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT04155008 is a Phase 4 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 1 participants.
The verdict
NCT04155008, a Phase 4 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatment and improve the quality of life of patients by implementing an algorithm utilizing nutrition intervention and appetite stimulants.
Interventions
- DRUG Dexamethasone
- DRUG Dronabinol
- BEHAVIORAL Nutrition Intervention
- DRUG Mirtazapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2021-04-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04155008
The ClinicalTrials.gov registry entry for NCT04155008 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Dexamethasone is the first listed.
NCT04155008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04155008 about?
NCT04155008 is a clinical study titled "Nutrition and Pharmacological Algorithm for Oncology Patients Study". Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatme...
What is the current status of trial NCT04155008?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2021-03-01. Estimated completion is 2021-04-05.
What interventions are being tested in trial NCT04155008?
The interventions under investigation include: Dexamethasone (DRUG), Dronabinol (DRUG), Nutrition Intervention (BEHAVIORAL), Mirtazapine (DRUG).
Who is sponsoring clinical trial NCT04155008?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.